Roham T. Zamanian
Expertise in
5
conditions

Dr. Roham T. Zamanian

Pulmonary Medicine
Stanford Hospital And Clinics
300 Pasteur Dr # H3143H3143, 
Stanford, CA 
Expertise in
5
conditions
Stanford Hospital And Clinics
300 Pasteur Dr # H3143H3143, 
Stanford, CA 

Overview

Roham Zamanian is a Pulmonary Medicine provider practicing medicine in Stanford, California.

Dr. Zamanian is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Systemic Sclerosis (SSc), Cerebral Hypoxia, and Lung Transplant.

He is actively involved in clinical research, co-authoring 159 peer reviewed articles and participating in 7 clinical trials.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in CA

Hospital Affiliations

Stanford Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AllCare Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Stanford Hospital and Clinics
300 Pasteur Dr # H3143H3143, Stanford, CA 94305

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects
Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects
Enrollment Status: Completed
Publish Date: August 15, 2024
Intervention Type: Drug
Study Phase: Phase 1
Pulmonary Hypertension and Anastrozole Trial (PHANTOM)
Pulmonary Hypertension and Anastrozole Trial (PHANTOM)
Enrollment Status: Completed
Publish Date: May 01, 2024
Intervention Type: Drug
Study Drug: Anastrozole
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
A Double-blinded, Placebo-controlled Pilot Study of Dimethyl Fumarate (DMF) in Pulmonary Arterial Hypertension (PAH) Associated With Systemic Sclerosis (SSc-PAH): The Effect of DMF on Clinical Disease and Biomarkers of Oxidative Stress.
A Double-blinded, Placebo-controlled Pilot Study of Dimethyl Fumarate (DMF) in Pulmonary Arterial Hypertension (PAH) Associated With Systemic Sclerosis (SSc-PAH): The Effect of DMF on Clinical Disease and Biomarkers of Oxidative Stress.
Enrollment Status: Terminated
Publish Date: March 17, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

159 Total Publications

Expert Consensus to Explore the Definition and Characterization of Methamphetamine-Associated Pulmonary Arterial Hypertension and Key Treatment Considerations.
Expert Consensus to Explore the Definition and Characterization of Methamphetamine-Associated Pulmonary Arterial Hypertension and Key Treatment Considerations.
Journal: CHEST pulmonary
Published: August 04, 2026
Similar Doctors
Expertise in
14
conditions
Dr. Kaissa K. De Boer
Pulmonary Medicine
Expertise in
14
conditions
Dr. Kaissa K. De Boer
Pulmonary Medicine
Referral may be required

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (1.7 miles away)
650-723-4000
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kaissa De Boer is a Pulmonary Medicine provider practicing medicine in Palo Alto, California. She has been practicing medicine for over 18 years. Dr. De Boer is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Pneumonia.

Expertise in
4
conditions
Dr. Edda F. Spiekerkoetter
Pulmonary Medicine
Expertise in
4
conditions
Dr. Edda F. Spiekerkoetter
Pulmonary Medicine
Referral may be required

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (1.1 miles away)
650-723-6381
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Edda Spiekerkoetter is a Pulmonary Medicine provider practicing medicine in Stanford, California. Dr. Spiekerkoetter is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Arteriovenous Malformation, Cerebral Hypoxia, and Lung Transplant.

Expertise in
22
conditions
Dr. Harmeet S. Bedi
Pulmonary Medicine
Expertise in
22
conditions
Dr. Harmeet S. Bedi
Pulmonary Medicine
Referral may be required

Stanford Interventional Pulmonology

300 Pasteur Dr, 
Stanford, CA 
 (1.1 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Harmeet Bedi is a Pulmonary Medicine provider practicing medicine in Stanford, California. Dr. Bedi is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Acute Interstitial Pneumonia, Pleural Effusion, Advanced Bronchoscopy, and Endoscopy.

Expertise in
4
conditions
Dr. John L. Stauffer
Pulmonary Medicine
Expertise in
4
conditions
Dr. John L. Stauffer
Pulmonary Medicine
Referral may be required

Office

3172 Porter Dr, 
Palo Alto, CA 
 (1.4 miles away)
650-384-8091
Languages Spoken:
English

John Stauffer is a Pulmonary Medicine provider practicing medicine in Palo Alto, California. Dr. Stauffer is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Interstitial Lung Disease, and Acute Interstitial Pneumonia.

Expertise in
5
conditions
Dr. Mark R. Nicolls
Pulmonary Medicine
Expertise in
5
conditions
Dr. Mark R. Nicolls
Pulmonary Medicine
Referral may be required

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (1.1 miles away)
650-725-7061
Languages Spoken:
English
See accepted insurances

Mark Nicolls is a Pulmonary Medicine provider practicing medicine in Stanford, California. Dr. Nicolls is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Pulmonary Hypertension, Bronchiolitis Obliterans, Chronic Graft Versus Host Disease (cGvHD), and Lung Transplant.

Expertise in
11
conditions
Dr. Tushar J. Desai
Pulmonary Medicine
Expertise in
11
conditions
Dr. Tushar J. Desai
Pulmonary Medicine
Referral may be required

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (1.1 miles away)
650-725-7061
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tushar Desai is a Pulmonary Medicine provider practicing medicine in Stanford, California. Dr. Desai is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, Lung Metastases, and Lung Transplant.

Frequently Asked Questions about Dr. Roham T. Zamanian

How do I make an appointment with Dr. Roham T. Zamanian?

You can book an appointment with Dr. Roham T. Zamanian by calling their office at 650-723-6381. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Roham T. Zamanian a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Roham T. Zamanian is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Roham T. Zamanian specialize in?

While Dr. Roham T. Zamanian is a Pulmonary Medicine, they have specific expertise in Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Systemic Sclerosis (SSc). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Roham T. Zamanian participate in research or clinical trials?

Yes. Dr. Roham T. Zamanian has published 159 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Roham T. Zamanian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Roham T. Zamanian accept my insurance?

Dr. Roham T. Zamanian accepts most major insurance plans, including Aetna and AllCare Health. We recommend calling the office directly at 650-723-6381 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zamanian's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile